In the United States on July 27, will start clinical vaccine trials from COVID-19

American biotechnology company Moderna will begin clinical trials of a vaccine against coronavirus new type on July 27, reports CNBC, citing the database of the US government.

The trials will involve around 30 thousand volunteers. Everyone will get a dose of potential vaccines in the amount of 0,1 milligram, 29 days of injection will be repeated. Some participants will be vaccinated with the drug-placebo.

Project vaccine company supports the US Federal government, which allocated nearly $ 500 million and selected it as one of the first to start large scale human trials. A week ago, Reuters reported that relations between the company and government scientists have been tensions.

Three sources familiar with the vaccine project, told the news Agency that Moderna, which has not yet produced an approved vaccine and has not conducted large trials disagreed with government scientists, has not sent on time protocols testing and rejected the advice of experts for the study. This led to the delay of vaccine trials.

Recent data on the situation of COVID-19 in Russia and the world presented on the portal stopmanager.of the Russian Federation.